A McGill-led study is challenging a popular theory about how dopamine drives movement, a discovery that could shift how ...

A McGill-led study is challenging a popular theory about how dopamine drives movement, a discovery that could shift how ...

Explore dopamine's role in movement and how it challenges long-standing theories about motor control and Parkinson's disease ...

The brain-chemical surge that comes with running may bolster coordination and speed in the old and young alike, a new study ...

Parkinson's disease (PD) is an age-related, progressive, neurodegenerative condition, caused by loss of dopamine-producing neurons.

Overactivation of dopamine neurons may directly drive their death, explaining why movement-controlling brain cells degenerate in Parkinson’s. Mice with chronically stimulated neurons showed the same ...

Researchers from the Champalimaud Foundation shed light on the puzzling relationship between dopamine and rest tremor in Parkinson’s disease, finding that preserved dopamine in certain brain regions ...

On the same day that some Parkinson’s disease drugs are being called into question, AbbVie has announced that its late-stage monotherapy candidate has significantly reduced the burden of the disease ...

Dopamine doesn’t flood the brain as once believed – it fires in exact, ultra-fast bursts that target specific neurons. The discovery turns a century-old view of dopamine on its head and could ...

The U.S. Food and Drug Administration is reviewing a new Parkinson’s disease drug called tavapadon that could give people with the disease more control over their movements. If approved, it would be ...

Parkinson's disease, a degenerative brain condition primarily marked by the loss of muscle control, has been thrust into the media over the years in film and television. But there's still a ton of ...